The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...

Their availability without a prescription and recognized safety records further increase their common usage. The Antimigraine segment is projected to see the fastest growth, driven by the rising ...

The US Department of Justice (DOJ) has filed a lawsuit against Walgreens (WBA), one of the nation's largest pharmacy chains, alleging widespread prescription drug practice violations. According to ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

The four major Medicare parts (A, B, C, D) all offer some prescription drug coverage. Medicare Part D offers the most extensive outpatient prescription drug coverage ...

However, placebo usage may present ethical concerns in the postoperative care of TKA surgery; we therefore adopted an active-control trial design that compared celebrex treatment to the standard ...

But some lenders allow you to apply without a co-signer, basing your eligibility on your credit or factors like grades and future income potential. Review our picks for student loans without a co ...

Keep reading to learn more about how an exercise, recovery, and eating plan can help you lose fat without losing muscle. Many behavioral, hormonal, genetic, medical, and environmental factors ...